Kyverna Therapeutics, Inc. (KYTX) ROA
- 2026-06-30: ROA -69.44%.
- 2026-03-31: ROA -60.85%.
- 2025-12-31: ROA -54.90%.
- 2025-09-30: ROA -86.02%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -69.44% |
| 2026-03-31 | -60.85% |
| 2025-12-31 | -54.90% |
| 2025-09-30 | -86.02% |
| 2025-06-30 | -70.06% |
| 2025-03-31 | -55.79% |
| 2024-12-31 | -41.84% |
| 2024-09-30 | -32.62% |
| 2024-06-30 | -25.23% |
| 2024-03-31 | -19.47% |
| 2023-12-31 | -80.28% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -54.90% |
| 2024-12-31 | -41.84% |
| 2023-12-31 | -80.28% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |